The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Sickle cell disease can be life-threatening and cause recurring intense pain, when blood vessels become blocked by misshapen red cells. About 15,000 people ... hospital and may have side effects ...

Sickle cell is a blood disorder in which a ... plans it may be a little bit difficult to accommodate those costs." So far, the slow ramp up of patients in treatment has made coverage of early ...

At least 29 recruits have died during basic training at law enforcement academies nationwide in the last decade.

Sickle cell disease (SCD) has been historically overlooked and underfunded. For years, people living with SCD ... difficulties that many patients may face in pursuing innovative treatment options.

Our independent appraisal committee has approved the use of gene editing therapy exagamglogene autotemcel (exa-cel) for use in the NHS in England, providing a potential cure for some people with ...

Despite India's vast population of 1.4 billion, the country faces a shortage of stem cell ... someone in desperate need of help gives you a sense of fulfilment, says Paul. It might be the sole ...

While the cost may seem ... Uganda has the potential to lead the fight against this condition and ensure healthier generations to come,” he says. Symptoms People with sickle cell disease often ...

Given the remarkable advances seen with gene therapies for sickle cell disease (SCD), it may seem counterintuitive to suggest the space may be in need of more therapies that have already been ...

People with SCD have a special type of hemoglobin that does not carry oxygen as well compared to those who have a healthier type of protein. When sickle hemoglobin releases oxygen, it clumps together ...